Prostatis Group’s iShares 1-5 Year Investment Grade Corporate Bond ETF IGSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-42,332
Closed -$2.32M 101
2021
Q2
$2.32M Buy
42,332
+2,354
+6% +$129K 1.58% 18
2021
Q1
$2.19M Buy
39,978
+10,148
+34% +$557K 1.72% 16
2020
Q4
$1.65M Buy
+29,830
New +$1.64M 1.38% 19

Other funds holding IGSB

Prostatis Group's IGSB Position: Q3 2021 in Review

Prostatis Group sold out of iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) in Q3 2021, closing a stake of 42,332 shares — an estimated $2.32M sold.

Prostatis Group first reported a position in IGSB in Q4 2020 and held it in 3 quarters. The position peaked at $2.32M in Q2 2021. 906 funds tracked by Wall St. Rank hold IGSB as of Q3 2021.

  • Prostatis Group reported no remaining iShares 1-5 Year Investment Grade Corporate Bond ETF position as of Q3 2021 after selling out during the quarter.
  • Prostatis Group sold 42,332 iShares 1-5 Year Investment Grade Corporate Bond ETF shares in Q3 2021, an estimated $2.32M.
  • Prostatis Group first reported a position in iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2020 and held it in 3 quarters.
  • Prostatis Group's iShares 1-5 Year Investment Grade Corporate Bond ETF position peaked at $2.32M in Q2 2021.
  • 906 funds tracked by Wall St. Rank held iShares 1-5 Year Investment Grade Corporate Bond ETF as of Q3 2021.

Based on Prostatis Group's 13F filing for Q3 2021, filed 23 Mar 2023.